🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in South Korea / NCT07511634
Starting soon Not applicable

Comparison of Sevoflurane and Desflurane on ANI in Patients Undergoing General Anesthesia: a Prospective Randomized Controlled Study

NCT07511634 · tracked via the Priya Life Science South Korea tracker
Phase
Not applicable
Started
2026-04-01
Last updated
2026-04-06

Condition(s) studied

General Anesthesia

Investigational drug(s) / intervention(s)

Desflurane →Sevoflurane →

Desflurane: Desflurane will be administered for maintenance of general anesthesia after loss of consciousness following propofol induction. End-tidal desflurane concentration will be titrated to age-adjusted 1.0 MAC (±0.1 MAC) at the time of ANI assessment.

Sevoflurane: Sevoflurane will be administered for maintenance of general anesthesia after loss of consciousness following propofol induction. End-tidal sevoflurane concentration will be titrated to age-adjusted 1.0 MAC (±0.1 MAC) at the time of ANI assessment.

Study summary

This prospective randomized controlled study will compare the effects of sevoflurane and desflurane on the Analgesia Nociception Index (ANI) in adult patients undergoing general anesthesia. Participants will be randomized to maintenance anesthesia with either sevoflurane or desflurane, and ANI responses to a standardized nociceptive stimulus will be measured under equi-minimum alveolar concentration (age-adjusted 1.0 MAC) conditions. The primary objective is to compare the change in ANI before and after tetanic stimulation between the two anesthetic groups. Secondary measurements will include bispectral index, blood pressure, heart rate, and end-tidal anesthetic concentration around the time of stimulation.

Eligibility

Sex
ALL
Min age
19 Years
Max age
79 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 19 to 79 years * Patients undergoing general anesthesia * American Society of Anesthesiologists (ASA) physical status I or II Exclusion Criteria: * History of taking medications that may affect the central nervous system or autonomic nervous system (e.g., anticholinergics, beta-blockers, antidepressants, anxiolytics, hypnotics, or analgesics) * Known hypersensitivity to sevoflurane, desflurane, or other halogenated anesthetics, or a personal or family history of malignant hyperthermia * Neurologic or psychiatric disorders (e.g., depression, dementia, or cerebral infarction) * Arrhythmia * Diabetes mellitus * Drug abuse or alcohol abuse * Vulnerable subjects * Patients aged 80 years or older * Patients with impaired consciousness or those judged to lack the capacity to provide informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Pusan National University Yangsan Hospital Yangsan Gyeongsangnam-do

More Pusan National University Yangsan Hospital trials in South Korea

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07511634 on ClinicalTrials.gov ↗ ← All trials in South Korea